Tradestie Institutional Equity Comparison Engine
ATOS vs PTN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ATOS Overall Edge
ATOS Captures Institutional Edge (4โ0 Pillars ยท 9โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Atossa Therapeutics, Inc. Common Stock (ATOS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ATOS trades at 7.0x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus PTN at 42.9x Forward P/E and -65.7% operating margin (-80.1% YoY). In options structure, ATOS sits in BREAKDOWN (37th %ile IV; Dealer Gamma Walls on Pro) against PTN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
ATOS
ATOS 7.0x vs PTN 42.9x Fwd P/E
Growth & Margin Winner
ATOS
Op Margin 0.0% vs -65.7% ยท YoY +0.0% vs -80.1%
Momentum & Technical Winner
ATOS
1Y +140.4% vs -43.3% ยท 52W Pos 20% vs 6%
Options & Structure Winner
ATOS
BREAKDOWN (37th %ile IV) vs UNCLASSIFIED (N/A IV)
ATOS
NASDAQ
Atossa Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$1.93
-1.53% 1D
Market Cap
$19.6M
1M Return
-33.68%
1Y Return
+140.44%
Forward P/E
7.0x
Unified AI Score
59.2 / 100
HOLD
Tech 70.0
Fund 65.0
Flow 64.0
Mom 60.0
PTN
US Equity
Palatin Technologies, Inc.
Pharmaceutical Preparations
$6.12
-1.69% 1D
Market Cap
$11.1M
1M Return
+1.74%
1Y Return
-43.29%
Forward P/E
42.9x
Unified AI Score
31.5 / 100
SELL
Tech 15.0
Fund 30.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ATOS +140.44%
PTN -43.29%
Spread: +183.73 pp (ATOS Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ATOS Revenue | PTN Revenue | ATOS Op. Margin | PTN Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2017 | N/A | $70M | N/A | 38.6% | PTN |
| FY2018 | N/A | $70M | N/A | 38.6% | PTN |
| FY2019 | N/A | $60M | N/A | 59.3% | PTN |
| FY2020 | N/A | $0M | N/A | -20007.6% | PTN |
| FY2022 | N/A | $0M | N/A | -2491.6% | PTN |
| FY2023 | N/A | $0M | N/A | -668.7% | PTN |
| FY2024 | N/A | $0M | N/A | -501.0% | PTN |
| FY2026 | N/A | $10M | N/A | -65.7% | PTN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ATOS | PTN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $19.6M | $11.1M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 7.0x | 42.9x | Lower Multiple | ATOS |
| Forward P/E Ratio Valuation | 7.0x | 42.9x | Lower Multiple | ATOS |
| Revenue Growth (YoY) Growth | +0.0% | -80.1% | Higher Growth | ATOS |
| Operating Margin (TTM) Profitability | 0.0% | -65.7% | Higher Margin | ATOS |
| Net Profit Margin Profitability | 0.0% | -63.5% | Higher Margin | ATOS |
| Return on Equity (ROE) Capital Efficiency | -96.9% | -877.5% | Higher ROE | ATOS |
| 52-Week Range Position Momentum | 20% ($1โ$8) | 6% ($5โ$31) | Stronger Trend | ATOS |
| Beta / 30D Volatility Risk Regime | 0.35ฮฒ ยท 67% Vol | 0.87ฮฒ ยท 106% Vol | Lower Realized Risk | ATOS |
| Unified Institutional Score Composite Signal | 59.2 / 100 (HOLD) | 31.5 / 100 (SELL) | Higher Composite | ATOS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ATOS vs PTN Buy Guide
ATOS
BREAKDOWN
64d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
37th %ile
IV Regime
Balanced (25thโ60th %ile)
PTN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ATOS nor PTN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.